|
Volumn 120, Issue 2, 2000, Pages 350-358
|
Recombinant human complement C5A receptor antagonist reduces infarct size after surgical revascularization
a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
CGS 32359;
COMPLEMENT COMPONENT C5A RECEPTOR;
COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
CORONARY ARTERY BLOOD FLOW;
DRUG EFFECT;
HEART INFARCTION;
HEART INFARCTION SIZE;
HEART MUSCLE ISCHEMIA;
LEUKOCYTE ACTIVATION;
NONHUMAN;
PRIORITY JOURNAL;
|
EID: 0033861770
PISSN: 00225223
EISSN: None
Source Type: Journal
DOI: 10.1067/mtc.2000.107281 Document Type: Article |
Times cited : (44)
|
References (31)
|